Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yubin Ge

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Plos One|October 8, 2013
Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cellsGuan Wang, Holly Edwards, J Timothy Caldwell, et al.
Plos One|February 27, 2026
Transcranial direct current stimulation with Bosu-ball training increases cortical activation and improves ankle-foot function among individuals with chronic ankle instability: A randomized controlled trialXin Luo, Peixin Shen, Xueke Huang, et al.
Journal of Cellular and Molecular Medicine|March 31, 2022
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemiaHanxi Yu, Shuangshuang Wu, Shuang Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndromeHiroto Inaba, Margherita Londero, Scott H Maurer, et al.
Targeted Oncology|May 23, 2019
Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex VivoFangbing Liu, Tristan Knight, Yongwei Su, et al.
Cells|September 9, 2022
Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of <i>FLT3</i>-Mutated Acute Myeloid LeukemiaShuangshuang Wu, Holly Edwards, Deying Wang, et al.
Signal Transduction and Targeted Therapy|November 9, 2019
Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemiaTingting Wang, Margaret Shatara, Fangbing Liu, et al.
Signal Transduction and Targeted Therapy|December 18, 2020
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapyJenna L Carter, Katie Hege, Jay Yang, et al.
Biochemical Pharmacology|June 22, 2026
Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasmsKian K Hershberger, Jenna Thibodeau, Yongwei Su, et al.
Journal of Pediatric Hematology/Oncology|February 25, 2017
Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 CasesZhihong J Wang, Yubin Ge, Deniz Altinok, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Plos One|October 8, 2013
Panobinostat synergistically enhances the cytotoxic effects of cisplatin, doxorubicin or etoposide on high-risk neuroblastoma cellsGuan Wang, Holly Edwards, J Timothy Caldwell, et al.
Plos One|February 27, 2026
Transcranial direct current stimulation with Bosu-ball training increases cortical activation and improves ankle-foot function among individuals with chronic ankle instability: A randomized controlled trialXin Luo, Peixin Shen, Xueke Huang, et al.
Journal of Cellular and Molecular Medicine|March 31, 2022
Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemiaHanxi Yu, Shuangshuang Wu, Shuang Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2011
Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndromeHiroto Inaba, Margherita Londero, Scott H Maurer, et al.
Targeted Oncology|May 23, 2019
Venetoclax Synergistically Enhances the Anti-leukemic Activity of Vosaroxin Against Acute Myeloid Leukemia Cells Ex VivoFangbing Liu, Tristan Knight, Yongwei Su, et al.
Cells|September 9, 2022
Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of <i>FLT3</i>-Mutated Acute Myeloid LeukemiaShuangshuang Wu, Holly Edwards, Deying Wang, et al.
Signal Transduction and Targeted Therapy|November 9, 2019
Simultaneous cotargeting of ATR and RNA Polymerase I transcription demonstrates synergistic antileukemic effects on acute myeloid leukemiaTingting Wang, Margaret Shatara, Fangbing Liu, et al.
Signal Transduction and Targeted Therapy|December 18, 2020
Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapyJenna L Carter, Katie Hege, Jay Yang, et al.
Biochemical Pharmacology|June 22, 2026
Breaking the guardian of the genome: TP53 dysfunction in myeloid neoplasmsKian K Hershberger, Jenna Thibodeau, Yongwei Su, et al.
Journal of Pediatric Hematology/Oncology|February 25, 2017
Concomitant Use of Panobinostat and Reirradiation in Progressive DIPG: Report of 2 CasesZhihong J Wang, Yubin Ge, Deniz Altinok, et al.
Pageof 14